Arbelaez A

Broide E

Castillo M

Elpeleg O

CiteSeerX

3-METHYLGLUTACONIC ACIDURIA TYPE III (MGA TYPE III) REFERENCES 
(OPTIC ATROPHY PLUS SYNDROME; IRAQI-JEWISH 'OPTIC ATROPHY PLUS'; MGA, TYPE III; 
COSTEFF SYNDROME) 
 
1.  Al-Essa M, Bakheet S, Al-Shamsan L, Patay Z, Powe J, Ozand PT. “18fluoro-2-deoxyglucose 
(18FDG) PET scan of the brain in type IV 3-methylglutaconic aciduria: clinical and MRI 
correlation,” Brain Dev 1999; 21(1): 24-29. 
2.  al Aqeel A, Rashed M, Ozand PT, Brismar J, Gascon GG, al Odaib A, Dabbagh O. “3-
methylglutaconic aciduria: ten new cases with a possible new phenotype,” Brain Dev. 1994 Nov; 
16 Suppl: 23-32. 
3.  Anikster Y, Kleta R, Shaag A, Gahl WA, Elpeleg O. “Type III 3-methylglutaconic aciduria (optic 
atrophy plus syndrome, or costeff optic atrophy syndrome): identification of the OPA3 gene and 
its found mutation in Iraqi Jews,” Am J Hum Genet 2001; 69(6): 1218-1224. 
4.  Arbelaez A, Castillo M, Stone J. “MRI in 3-methylglutaconic aciduria type 1,” Neuroradiology 
1999; 41(12): 941-942. 
5.  Bakkeren JA, Sengers RC, Ruitenbeek W, Trijbels JM. “3-methylglutaconic aciduria in a patient 
with a disturbed mitochondrial energy metabolism,” Eur J Pediatr. 1992 Apr; 151(4): 313. 
6.  Barth PG, Wanders RJ, Vreken P. “X-linked cardioskeletal myopathy and neutropenia (barth 
syndrome)- MIM 302060,” J Pediatr 1999; 135(3): 273-276. 
7.  Barth PG, Wanders RJ, Vreken P, Janssen EA, Lam J, Baas F. “X-linked cardioskeletal myopathy 
and neutropenia (barth syndrome) (MIM 302060),” J Inherit Metab Dis 1999; 22(4): 555-567. 
8.  Besley GT, Lendon M, Broadhead DM, Till J, Heptinstall LE, Phillips B. “Mitochondrial complex 
deficiencies in a male with cardiomyopathy and 3-methylglutaconic aciduria,” J Inherit Metab 
Dis. 1995; 18(2): 221-3. 
9.  Brandt NJ. “Symptoms and Signs in Organic Acidurias,” J Inher Metab Dis 1984, 7(suppl 1): 23-
27. 
10.  Broide E, Elpeleg O, Lahat E. “Type IV 3-methylglutaconic (3-MGC) aciduria: a new case 
presenting with hepatic dysfunction,” Pediatr Neurol 1997; 17(4): 353-355. 
11.  Burlina A, Manara R, Calderone M, Catuogno S, Burlina AP. “Early diagnosis of metabolic stroke 
in branched-chain organic acidurias without metabolic decompensation,” J Inherit Metab Dis 
2002; 25(suppl.1): 45. 
12.  Cantlay AM, Shokrollahi K, Allen JT, Lunt PW, Newbury-Ecob RA, Steward CG. “Genetic 
analysis of the G4.5 gene in families with suspected barth syndrome,” J Pediatr 1999; 135(3): 
311-315. 
13.  Cardonick EH, Kuhlman K, Ganz E, Pagotto LT. “Prenatal clinical expression of 3-
methylglutaconic aciduria: barth syndrome,” Prenat Diagn 1997; 17(10): 983-988. 
14.  Chace DH, DiPerna JC, Mitchell BL, Sgroi B, Hofman LF, Naylor EW. “Electrospray Tandem 
Mass Spectrometry for Analysis of Acylcarnitines in Dried Postmortem Blood Specimens 
Collected at Autopsy from Infants with Unexplained Cause of Death,” Clin Chem 2001; 47(7): 
1166-1182. 
15.  Chitayat D, Chemke J, Gibson KM, Mamer OA, Kronick JB, McGill JJ, Rosenblatt B, Sweetman 
L, Scriver CR. “3-methylglutaconic aciduria: a marker for as yet unspecified disorders and the 
relevance of prenatal diagnosis in a 'new' type ('type 4'),” J Inherit Metab Dis. 1992; 15(2): 204-
12. 
16.  Costeff H, Apter N, Elpeleg ON, Prialnic M, Bohles HJ. “Ineffectiveness of oral coenzyme Q10 
supplementation in 3-methylglutaconic aciduria, type 3,” Brain Dev 1998; 20(1): 33-35. 
17.  Costeff H, Elpeleg ON. “3-methylglutaconic aciduria, type 3,” Brain Dev 1995; 17(3): 226. 
18.  Costeff H, Elpeleg O, Apter N, Divry P, Gadoth N. “3-methylglutaconic aciduria in ‘optic atrophy 
plus,” Ann Neurol. 1993 Jan; 33(1): 103-4. 
19.  Christodoulou J, McInnes RR, Jay V, Wilson G, Becker LE, Lehotay DC, Platt BA, Bridge PJ, 
Robinson BH, Clarke JT. “Barth syndrome: clinical observations and genetic linkage studies,” Am 
J Med Genet. 1994 Apr 15; 50(3): 255-64. 
20.  deKoning T, Duran M, Dorland L, Berger R, Poll-The BT. “Maternal 3-methylglutaconic aciduria 
associated with abnormalities in offspring,” Lancet 1996; 348(9031: 887-888. 21.  Draaisma JM, van Kesteren IC, Daniels O, Sengers RC. “Dilated cardiomyopathy with 3-
methylglutaconic aciduria,” Pediatr Cardiol. 1994 Mar-Apr; 15(2): 89-90. 
22.  Duran M, Beemer FA, Tibosch AS, Bruinvis L, Ketting D, Wadman SK. “Inherited 3-
methylglutaconic aciduria in two brothers--another defect of leucine metabolism,” J Pediatr. 1982 
Oct; 101(4): 551-4. 
23.  Elpeleg ON, Costeff H, Joseph A, Shental Y, Weitz R, Gibson KM. “3-methylglutaconic aciduria 
in the Iraqi-Jewish 'optic atrophy plus' (costeff) syndrome,” Dev Med Child Neurol. 1994 Feb; 
36(2): 167-72. 
24.  Ensenauer R, Muller CB, Schwab KO, Gibson KM, Brandis M, Lehnert W. “3-methylglutaconyl-
CoA hydratase deficiency: a new patient with speech retardation as the leading sign,” J Inherit 
Metab Dis 2000; 23(4): 341-344. 
25.  Gibson KM, Bennett MJ, Mize CE, Jakobs C, Rotig A, Munnich A, Lichter-Konecki U, Trefz FK. 
“3-methylglutaconic aciduria associated with pearson syndrome and respiratory chain defects,” J 
Pediatr. 1992 Dec; 121(6): 940-2. 
26.  Gibson KM, Lee CF, Wappner RS. “3-methylglutaconyl-coenzyme-A hydratase deficiency: a new 
case,” J Inherit Metab Dis. 1992; 15(3): 363-6. 
27.  Gibson KM, Wappner RS, Jooste S, Erasmus E, Mienie LJ, Gerlo E, Desprechins B, De Meirleir 
L. “Variable clinical presentation in three patients with 3-methylglutaconyl-coenzyme A hydratase 
deficiency,” J Inherit Metab Dis 1998; 21(6): 631-638. 
28.  Holme E, Greter J, Jacobson CE, Larsson NG, Lindstedt S, Nilsson KO, Oldfors A, Tulinius M. 
“Mitochondrial ATP-synthase deficiency in a child with 3-methylglutaconic aciduria,” Pediatr 
Res. 1992 Dec; 32(6): 731-5. 
29.  Holtmann MG, Galle PR, Stremmel W, Mayatepek E. “3-methylglutaconic aciduria associated 
with hepatosplenomegaly, macrocytic anaemia, fever episodes, recurrent infections, cervical 
lymphadenopathy and progressive decrease of physical performance,” J Inherit Metab Dis 1998; 
21(6): 683-685. 
30.  Hou JW, Wang TR. “3-methylglutaconic aciduria presenting as reye syndrome in a chinese boy,” 
J Inherit Metab Dis. 1995; 18(5): 645-6. 
31.  Ibel H, Endres W, Hadorn HB, Deufel T, Paetzke I, Duran M, Kennaway NG, Gibson KM. 
“Multiple respiratory chain abnormalities associated with hypertrophic cardiomyopathy and 3-
methylglutaconic aciduria,” Eur J Pediatr. 1993 Aug; 152(8): 665-70. 
32.  Ijlst L, Loupatty FJ, Ruiter JP, Duran M, Lehnert W, Wanders RJ. “3-methylglutaconic aciduria 
type I is caused by mutations in AUH,” Am J Hum Genet 2002, 71(6): 1463-1466. 
33.  Johnston J, Kelley RI, Feigenbaum A, Cox GF, Iyer GS, Funanage VL, Proujansky R. “Mutation 
characterization and genotype-phenotype correlation in barth syndrome,” Am J Hum Genet 1997; 
61(5): 1053-1058. 
34.  Jooste S, Erasmus E, Mienie LJ, de Wet WJ, Gibson KM. “The detection of 3-
methylglutarylcarnitine and a new dicarboxylic conjugate, 3-methylglutaconylcarnitine, in 3-
methylglutaconic aciduria,” Clin Chim Acta. 1994 Oct 14; 230(1): 1-8. 
35.  Kahler SG, Sherwood WG, Woolf D, Lawless ST, Zaritsky A, Bonham J, Taylor CF, Clarke JTR, 
Durie P, Leonard JV. “Pancreatitis in patients with organic acidemias,” J Pediatr 1994; 124(2): 
239-243. 
36.  Kelley RI, Cheatham JP, Clark BJ, Nigro MA, Powell BR, Sherwood GW, Sladky JT, Swisher 
WP. “X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-
methylglutaconic aciduria,” J Pediatr. 1991 Nov; 119(5): 738-47. 
37.  Kelley RI, Kratz L. “3-methylglutaconic acidemia in Smith-Lemli-Opitz syndrome,” Pediatr Res. 
1995 May; 37(5): 671-4. 
38.  Kleta R, Skovby F, Christensen E, Rosenberg T, Gahl WA, Anikster Y. “3-methylglutaconic 
aciduria type III in a non-Iraqi-Jewish kindred: clinical and molecular findings,” Mol Genet Metab 
2002; 76(3): 201-206. 
39.  Kuhara T, Matsumoto I, Saiki K, Takabayashi H, Kuwabara S. “3-methylglutaconic aciduria in 
two adults,” Clin Chim Acta. 1992 Apr 30; 207(1-2): 151-3. 
40.  Laube GF, Leonard JV, van't Hoff WG. “Nephrocalcinosis and medullary cysts in 3-
methylglutaconic aciduria,” Pediatr Nephrol. 2003 Jul; 18(7): 712-3. Epub 2003 May 15. 
41.  Lichter-Konecki U, Trefz FK, Rotig A, Munnich A, Pfeil A, Bremer HJ. “3-methylglutaconic 
aciduria in a patient with pearson syndrome,” Eur J Pediatr. 1993 Apr; 152(4): 378. 42.  Ly TB, Peters V, Gibson KM, Liesert M, Buckel W, Wilcken B, Carpenter K, Ensenauer R, 
Hoffmann GF, Mack M, Zschocke J. “Mutations in the AUH gene cause 3-methylglutaconic 
aciduria,” Hum Mutat 2003; 21(4): 401-407. 
43.  Mazzocco MM, Kelley RI. “Preliminary evidence for a cognitive phenotype in barth syndrome,” 
Am J Med Genet 2001; 102(4): 372-378. 
44.  Michelson M, Harel S, Gutman A, Lerman-Sagie T. “Urinary organic acid screening in children 
with developmental language delay,” J Inherit Metab Dis 1999; 22(7): 815-820. 
45.  Millington DS. “Interpretation and follow-up of abnormal newborn screening results from 
MS/MS,” 2004 Newborn Screening & Genetics Testing Symposium, May 3, 2004, Atlanta, GA 
46.  Morris AA, Leonard JV. “Early recognition of metabolic decompensation,” Arch Dis Child. 1997 
Jun; 76(6): 555-6. 
47.  Nysteun A, Costeff H, Elpeleg ON, Apter N, Bonne-Tamir B, Mohrenweiser H, Haider N, Stone 
EM, Sherrield VC. “Iraqi-Jewish kindreds with optic atrophy plus (3-methylglutaconic aciduria 
type 3) demonstrate linkage disequilibrium with the CTG repeat in the 3’ untranslated region of 
the myotonic dystrophy protein kinase gene,” Hum Mol Genet 1997; 6(4): 563-9. 
48.  Ogier H, Saudubray JM. “Branched-chain organic acidurias,” Semin Neonatol 2002; 7: 65-74. 
49.  OMIM- Online Mendelian Inheritance in Man; 3-@METHYLGLUTACONICACIDURIA, TYPE 
I-#250950.OMIM- Online Mendelian Inheritance in Man; 3-
@METHYLGLUTACONICACIDURIA, TYPE II-BARTH SYNDROME; BTHS- #302060. 
50.  OMIM- Online Mendelian Inheritance in Man; 3-@METHYLGLUTACONICACIDURIA, TYPE 
III-#258501. 
51.  OMIM- Online Mendelian Inheritance in Man; 3-@METHYLGLUTACONICACIDURIA, TYPE 
IV-250951. 
52.  Ostman-Smith I, Brown G, Johnson A, Land JM. “Dilated cardiomyopathy due to type II X-linked 
3-methylglutaconic aciduria: successful treatment with pantothenic acid,” Br Heart J. 1994 Oct, 
72(4): 349-53. 
53.  Pantaleoni C, D’Arrigo S, D’Incerti L, Rimoldi M, Riva D. “A case of 3-methylglutaconic 
aciduria misdiagnosed as cerebral palsy,” Pediatr Neurol 2000; 23(5): 442-444. 
54.  Rousson R, Guibaud P. “Long Term Outcome of Organic Acidurias: Survey of 105 French Cases 
(1967-1983),” J Inher Metab Dis 1984, 7(suppl 1): 10-12. 
55.  Sakamoto O, Kitoh T, Ohura T, Ohya N, Iinuma K. “Novel missense mutation (R94S) in the TAZ 
(G4.5) gene in a Japanese patient with Barth syndrome,” J Hum Genet 2002; 47(5): 229-231. 
56.  Seashore M. “The Organic Acidemias: An Overview,” www.geneclinics.org 
57.  Sheffer RN, Zlotogora J, Elpeleg ON, Raz J, Ben-Ezra D. “Behr's syndrome and 3-
methylglutaconic aciduria,” Am J Ophthalmol. 1992 Oct 15; 114(4): 494-7. 
58.  Shoji Y, Takahashi T, Sawaishi Y, Ishida A, Matsumori M, Shoji Y, Enoki m, Watanabe H, 
Takada G. “3-methylglutaconic aciduria type I: clinical heterogeneity as a neurometabolic 
disease,” J Inherit Metab Dis 1999; 22(1): 1-8. 
59.  Sweetman L. “Prenatal Diagnosis of the Organic Acidurias,” J Inher Metab Dis 1984, 7(suppl 1): 
18-22. 
60.  Sweetman L, Williams JC. Branched Chain Organic Acidurias In: C. Scriver, A.L. Beaudet, W. 
Sly and D. Valle, Editors, The Metabolic and Molecular Basis of Inherited Disease (eighth ed.), 
McGraw-Hill, New York (2001), pp. 2125–2163. 
61.  Walsh R, Conway H, Roche G, Naughten E, Mayne PD. “What is the origin of 3-
methylglutaconic acid?” J Inher Metab Dis 1999; 22: 251-155. 
62.  Walsh R, Conway H, Roche G, Naughten E, Mayne PD. “3-methylglutaconic aciduria in 
pregnancy,” Lancet 1997; 349(9054): 776. 
63.  Zeharia A, Elpeleg ON, Mukamel M, Weitz R, Ariel R, Mimouni M. “3-methylglutaconic 
aciduria: a new variant,” Pediatrics. 1992 Jun 89(6 Pt 1): 1080-2. 

atrophy plus syndrome, or costeff optic atrophy syndrome): identification of the OPA3 gene and its found mutation in Iraqi Jews, ” Am J Hum Genet 2001; 69(6): 1218-1224.

http://www.idph.state.ia.us/genetics/common/pdf/mga_type3_ref.pdf

atrophy plus syndrome, or costeff optic atrophy syndrome): identification of the OPA3 gene and its found mutation in Iraqi Jews, ” Am J Hum Genet 2001; 69(6): 1218-1224.

Abstract

Similar works

Full text

Available Versions

CiteSeerX